Prevention of post intravitreal injection endophthalmitis: Is antibioprophylaxis indicated?;Prévention de l'endophtalmie post injection intravitréenne : l'antibioprophylaxie a-t-elle sa place?

Journal Francais d'Ophtalmologie

Volumn 36, Issue 1, 2013, Pages 72-75

  Cochereau, I ^a   Korobelnik, J F ^b   Bodaghi, B ^c  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b BORDEAUX UNIVERSITY HOSPITAL   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Antibioprophylaxis; Intravitreal injection

Indexed keywords

ANTIINFECTIVE AGENT;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; ENDOPHTHALMITIS; HUMAN; INTRAVITREAL DRUG ADMINISTRATION; METHODOLOGY; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PROFESSIONAL PRACTICE; RISK ASSESSMENT; STATISTICS;

ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; ENDOPHTHALMITIS; HUMANS; INTRAVITREAL INJECTIONS; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; PROFESSIONAL PRACTICE; RISK ASSESSMENT;

EID: 84873737893     PISSN: 01815512     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jfo.2012.10.001     Document Type: Article

References (30)

1. J.F. Korobelnik, I. Cochereau, S.Y. Cohen, G. Coscas, C. Creuzot-Garcher, and F. Devin How to perform intravitreal injections? J Fr Ophtalmol 29 2006 82 86
2. M. Weber, S.Y. Cohen, R. Tadayoni, G. Coscas, C. Creuzot-Garcher, and F. Devin Evolving intravitreous injection technique J Fr Ophtalmol 31 2008 625 629
3. B. Bodaghi, J.F. Korobelnik, I. Cochereau, J. Hajjar, F. Goebel, and N. Dumarcet Intravitreal injections: Afssaps guide to good practice J Fr Ophtalmol 35 2012 69 71
4. M. Inoue, S. Kobayakawa, C. Sotozono, H. Komori, K. Tanaka, and Y. Suda Evaluation of the incidence of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor Ophthalmologica 226 2011 145 150
5. C.P. Shah, S.J. Garg, J.F. Vander, G.C. Brown, R.S. Kaiser, and J.A. Haller Outcomes and risk factors associated with endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents Ophthalmology 118 2011 2028 2034
6. C.A. McCannel Meta-analysis of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents: causative organisms and possible prevention strategies Retina 31 2011 654 661
7. A.A. Moshfeghi, P.J. Rosenfeld, H.W. Flynn Jr., S.G. Schwartz, J.L. Davis, and T.G. Murray Endophthalmitis after intravitreal anti-vascular endothelial growth factor antagonists: a six-year experience at a university referral center Retina 31 2011 662 668
8. C.S. Cheung, A.W. Wong, A. Lui, P.J. Kertes, R.G. Devenyi, and W.C. Lam Incidence of endophthalmitis and use of antibiotic prophylaxis after intravitreal injections Ophthalmology 119 2012 1609 1614
9. R.A. Goldberg, H.W. Flynn Jr., R.F. Isom, D. Miller, and S. Gonzalez An outbreak of streptococcus endophthalmitis after intravitreal injection of bevacizumab Am J Ophthalmol 153 2012 204 208 e201
10. J.C. Wen, C.A. McCannel, A.B. Mochon, and O.B. Garner Bacterial dispersal associated with speech in the setting of intravitreous injections Arch Ophthalmol 129 2011 1551 1554
11. R.R. Doshi, T. Leng, and A.E. Fung Reducing oral flora contamination of intravitreal injections with face mask or silence Retina 32 2012 473 476
12. E.S. Gragoudas, A.P. Adamis, E.T. Cunningham Jr., M. Feinsod, and D.R. Guyer Pegaptanib for neovascular age-related macular degeneration N Engl J Med 351 2004 2805 2816
13. Endophthalmitis study group European society of cataract & refractive surgeons Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors J Cataract Refract Surg 33 2007 978 988
14. J.M. Moss, S.R. Sanislo, and C.N. Ta A prospective randomized evaluation of topical gatifloxacin on conjunctival flora in patients undergoing intravitreal injections Ophthalmology 116 2009 1498 1501
15. O. Halachmi-Eyal, Y. Lang, Y. Keness, and D. Miron Preoperative topical moxifloxacin 0.5 % and povidone-iodine 5.0 % versus povidone-iodine 5.0 % alone to reduce bacterial colonization in the conjunctival sac J Cataract Refract Surg 35 2009 2109 2114
16. P. Costello, S.J. Bakri, P.M. Beer, R.J. Singh, N.S. Falk, and G.B. Peters Vitreous penetration of topical moxifloxacin and gatifloxacin in humans Retina 26 2006 191 195
17. E. Milder, J. Vander, C. Shah, and S. Garg Changes in antibiotic resistance patterns of conjunctival flora due to repeated use of topical antibiotics after intravitreal injection Ophthalmology 119 2012 1420 1424
18. S.B. Dave, H.S. Toma, and S.J. Kim Ophthalmic antibiotic use and multidrug-resistant staphylococcus epidermidis: a controlled, longitudinal study Ophthalmology 118 2011 2035 2040
19. S.J. Kim, and H.S. Toma Ophthalmic antibiotics and antimicrobial resistance a randomized, controlled study of patients undergoing intravitreal injections Ophthalmology 118 2011 1358 1363
20. S.J. Kim, and H.S. Toma Antimicrobial resistance and ophthalmic antibiotics: 1-year results of a longitudinal controlled study of patients undergoing intravitreal injections Arch Ophthalmol 129 2011 1180 1188
21. C.R. Alabiad, D. Miller, J.C. Schiffman, and J.L. Davis Antimicrobial resistance profiles of ocular and nasal flora in patients undergoing intravitreal injections Am J Ophthalmol 152 2011 999 1004 e1002
22. W. Haas, C.M. Pillar, M. Torres, T.W. Morris, and D.F. Sahm Monitoring antibiotic resistance in ocular microorganisms: results from the Antibiotic Resistance Monitoring in Ocular micRorganisms (ARMOR) 2009 surveillance study Am J Ophthalmol 152 2011 567 574 e563
23. R.E. Fintelmann, E.N. Hoskins, T.M. Lietman, J.D. Keenan, B.D. Gaynor, and V. Cevallos Topical fluoroquinolone use as a risk factor for in vitro fluoroquinolone resistance in ocular cultures Arch Ophthalmol 129 2011 399 402
24. D. Miller, P.M. Flynn, I.U. Scott, E.C. Alfonso, and H.W. Flynn Jr. In vitro fluoroquinolone resistance in staphylococcal endophthalmitis isolates Arch Ophthalmol 124 2006 479 483
25. A.R. Bhavsar, J.M. Googe Jr., C.R. Stockdale, N.M. Bressler, A.J. Brucker, and M.J. Elman Risk of endophthalmitis after intravitreal drug injection when topical antibiotics are not required: the diabetic retinopathy clinical research network laser-ranibizumab-triamcinolone clinical trials Arch Ophthalmol 127 2009 1581 1583
26. I. Cochereau, J.F. Korobelnik, P.Y. Robert, and J. Hajjar Antibioprophylaxis in ocular surgery: Afssaps recommendations J Fr Ophtalmol 34 2011 428 430
27. S. Gonzalez, P.J. Rosenfeld, M.W. Stewart, J. Brown, and S.P. Murphy Avastin doesn't blind people, people blind people Am J Ophthalmol 153 2012 196 203 e191
28. N.M. Yenerel, U.A. Dinc, and E. Gorgun A case of sterile endophthalmitis after repeated intravitreal bevacizumab injection J Ocul Pharmacol Ther 24 2008 362 363
29. S.S. Bhatt, K.E. Stepien, and K. Joshi Prophylactic antibiotic use after intravitreal injection: effect on endophthalmitis rate Retina 31 2011 2032 2036
30. C.C. Wykoff, and H.W. Flynn Jr. Endophthalmitis after intravitreal injection: prevention and management Retina 31 2011 633 635